8DR

(S)-2-(3-(benzo[c][1,2,5]thiadiazole-4-sulfonamido)thiophene-2-carboxamido)-5-guanidinopentanoic acid

Created:	2009-07-14
Last modified:	2020-06-05

Find Related PDB Entry
1 entries where 8DR is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	51
Chiral Atom Count	1
Bond Count	53
Aromatic Bond Count	15

2D diagram of 8DR

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(S)-2-(3-(benzo[c][1,2,5]thiadiazole-4-sulfonamido)thiophene-2-carboxamido)-5-guanidinopentanoic acid
Synonyms	(2S)-2-[[3-(2,1,3-benzothiadiazol-4-ylsulfonylamino)thiophen-2-yl]carbonylamino]-5-carbamimidamido-pentanoic acid
Systematic Name (OpenEye OEToolkits)	(2S)-2-[[3-(2,1,3-benzothiadiazol-4-ylsulfonylamino)thiophen-2-yl]carbonylamino]-5-carbamimidamido-pentanoic acid
Formula	C₁₇ H₁₉ N₇ O₅ S₃
Molecular Weight	497.572
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	11.02	O=C(O)C(NC(=O)c1sccc1NS(=O)(=O)c2cccc3nsnc23)CCCNC(=[N@H])N
SMILES	CACTVS	3.352	NC(=N)NCCC[CH](NC(=O)c1sccc1N[S](=O)(=O)c2cccc3nsnc23)C(O)=O
SMILES	OpenEye OEToolkits	1.7.0	c1cc2c(c(c1)S(=O)(=O)Nc3ccsc3C(=O)NC(CCCNC(=N)N)C(=O)O)nsn2
Canonical SMILES	CACTVS	3.352	NC(=N)NCCC[C@H](NC(=O)c1sccc1N[S](=O)(=O)c2cccc3nsnc23)C(O)=O
Canonical SMILES	OpenEye OEToolkits	1.7.0	[H]/N=C(/N)\NCCC[C@@H](C(=O)O)NC(=O)c1c(ccs1)NS(=O)(=O)c2cccc3c2nsn3
InChI	InChI	1.03	InChI=1S/C17H19N7O5S3/c18-17(19)20-7-2-4-11(16(26)27)21-15(25)14-10(6-8-30-14)24-32(28,29)12-5-1-3-9-13(12)23-31-22-9/h1,3,5-6,8,11,24H,2,4,7H2,(H,21,25)(H,26,27)(H4,18,19,20)/t11-/m0/s1
InChIKey	InChI	1.03	ZWWMEDURALZMEV-NSHDSACASA-N

Related Resource References

Resource Name	Reference
PubChem	44631827
ChEMBL	CHEMBL1078974

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.